Evotec
Itta MacNevin is a seasoned professional with extensive experience in business development within the pharmaceutical and biotechnology sectors. Currently serving as Senior Vice President and Head of Business Development for North America at Evotec since April 2015, Itta has held multiple senior leadership roles in the company, enhancing drug discovery capabilities through partnerships and consulting arrangements. Previously, at Scynexis from February 2005 to April 2015, Itta excelled in various roles including Business Development Specialist and Innovation Project Leader, contributing to integrated pharmaceutical solutions and drug development initiatives. Itta's earlier career includes consulting for Pharmasset, research at Emory University, and studies at the University of Richmond, culminating in a Master’s degree in Organic Chemistry from Emory University and a Bachelor’s degree in Chemistry, Business Administration, and Biology from the University of Richmond.
This person is not in the org chart
This person is not in any offices
Evotec
5 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.